In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Arachnova gets rights to Mitsubishi's MCI-225

Executive Summary

Arachnova Therapeutics Ltd. (finds new uses for current drugs) has licensed rights to use, in the development of its own compounds AA10021, AA10025, and AA10026, data Mitsubishi Pharma obtained while developing its MCI-225.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies